Our analysis further revealed that elevated expression of purine nucleotide metabolism enzymes (PRPS1, PPAT, PAICS, and PFAS) correlates with unfavorable clinical outcomes in NB patients. This evidence concerns the gene PRPS1 and neuroblastoma.